MEND offers an exciting new model of global healthcare delivery

• Led by a highly experienced "first-in-class" team from the pharma and biotechnology industry
• Seeks to create both economic and social value, but with priority placed on maximizing access to medicines that prevent amputation and death over financial gain
• Blends the best practices and operating principles of pharmaceutical and nonprofit organizations
• Employs a flexible, low cost corporate structure that minimizes administrative costs
• Seeks to minimize healthcare disparities and injustice by providing care to all patients, irrespective of socioeconomic status
• Prices products in line with patients' willingness and ability to pay
• Redeploys revenues generated from these products to sustain MEND's mission and promote lasting social change